Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5454194 | 0.85 | CYP3A4 (0.32) | — | |
| SCHEMBL2880133 | 0.79 | CYP3A4 (0.30) | — | |
| SCHEMBL8467150 | 0.79 | CYP3A4 (0.39) | SOAT2SOAT1 | |
| SCHEMBL3169255 | 0.76 | — | — | |
| SCHEMBL7059781 | 0.71 | ALDH1A1 (0.47) | — | |
| SCHEMBL27504866 | 0.71 | ADRA2A (0.39) | — | |
| SCHEMBL27908650 | 0.71 | GABRA1 (0.54) | — | |
| SCHEMBL27991666 | 0.70 | CD44 (0.36) | — | |
| SCHEMBL3963448 | 0.69 | CYP3A4 (0.41) | — | |
| SCHEMBL5266052 | 0.67 | TSHR (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624276-B2 | Compositions and methods for the dissolution of iron sulfide | SOLUGEN, INC. (US) | 2026-05-12 | — | — | US | claimed |
| EP-4090654-B1 | METHODS, PROCESSES AND INTERMEDIATES FOR PREPARING CHROMAN COMPOUNDS | LUPIN LTD (IN) | 2025-07-09 | — | — | EP | claimed |
| US-12344592-B2 | Methods, processes and intermediates for preparing chroman compounds | LUPIN LIMITED (IN) | 2025-07-01 | — | — | US | claimed |
| WO-2025042851-A1 | BIO-BASED DETERGENT BUILDER | SOLUGEN, INC. (US) | 2025-02-27 | — | — | WO | claimed |
| US-20230140054-A1 | METHODS, PROCESSES AND INTERMEDIATES FOR PREPARING CHROMAN COMPOUNDS | LUPIN LIMITED (IN) | 2023-05-04 | — | — | US | claimed |
| EP-4090654-A1 | METHODS, PROCESSES AND INTERMEDIATES FOR PREPARING CHROMAN COMPOUNDS | Lupin Limited (IN) | 2022-11-23 | — | — | EP | claimed |
| WO-2022226401-A1 | COMPOSITIONS AND METHODS FOR THE DISSOLUTION OF IRON SULFIDE | SOLUGEN, INC. (US) | 2022-10-27 | — | — | WO | claimed |
| WO-2021144814-A1 | METHODS, PROCESSES AND INTERMEDIATES FOR PREPARING CHROMAN COMPOUNDS | LUPIN LIMITED (IN) | 2021-07-22 | — | — | WO | claimed |
| US-9475889-B2 | Photoinitiator and photocurable compositions and uses | EASTMAN KODAK COMPANY (US) | 2016-10-25 | — | — | US | claimed |
| US-20150126637-A1 | PHOTOINITIATOR AND PHOTOCURABLE COMPOSITIONS AND USES | BANK OF AMERICA, N.A., AS AGENT | 2015-05-07 | — | — | US | claimed |
| EP-2710044-B1 | PHOTOINITIATOR AND PHOTOCURABLE COMPOSITIONS AND USES | EASTMAN KODAK CO (US) | 2015-04-01 | — | — | EP | claimed |
| EP-2710044-A1 | PHOTOINITIATOR AND PHOTOCURABLE COMPOSITIONS AND USES | Eastman Kodak Company (US) | 2014-03-26 | — | — | EP | claimed |
| US-8664287-B2 | Photocuring methods and articles prepared therefrom | Eastman Kodah Company (US) | 2014-03-04 | — | — | US | claimed |
| US-20120295035-A1 | PHOTOCURING METHODS AND ARTICLES PREPARED THEREFROM | BANK OF AMERICA, N.A., AS AGENT | 2012-11-22 | — | — | US | claimed |
| US-20120295999-A1 | PHOTOINITIATOR AND PHOTOCURABLE COMPOSITIONS AND USES | NPEC INC. | 2012-11-22 | — | — | US | claimed |
| WO-2012158660-A1 | PHOTOINITIATOR AND PHOTOCURABLE COMPOSITIONS AND USES | EASTMAN KODAK COMPANY (US) | 2012-11-22 | — | — | WO | claimed |
| EP-0531256-B1 | Method for preparing glycosides | CIBA GEIGY AG (CH) | 1997-04-23 | — | — | EP | claimed |
| US-5342929-A | Direct glycosylation leads to the desired glycosides in high yield and relatively short reaction times using metal complex salts; large amounts of the alpha- or beta-form are often obtained | CIBA-GEIGY CORPORATION (US) | 1994-08-30 | — | — | US | claimed |
| US-20260136848-A1 | DEPOSITION OF METAL-CONTAINING FILMS | LAM RES CORP (US) | 2026-05-14 | — | — | US | disclosed |
| US-4594463-A | HYDROFORMYULATION | UNION CARBIDE CORPORATION (US) | 1986-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230140054-A1 | METHODS, PROCESSES AND INTERMEDIATES FOR PREPARING CHROMAN COMPOUNDS | CASR, CALCR, RYR1 | SOAT2 3122/4885SOAT1 2804/4885 |
| US-20260136848-A1 | DEPOSITION OF METAL-CONTAINING FILMS | TPO, TTI2, ABL1 | SOAT2 856/4885SOAT1 1026/4885 |
| US-12344592-B2 | Methods, processes and intermediates for preparing chroman compounds | CASR, CALCR, RYR1 | SOAT2 3122/4885SOAT1 2804/4885 |
| US-12624276-B2 | Compositions and methods for the dissolution of iron sulfide | MGAT2, SLC7A11, CA1 | SOAT2 1240/4885SOAT1 1087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.